AstraZeneca, in collaboration with the National Primary Health Care Development Agency (NPHCDA) and the Population Services International (PSI) Nigeria, Thursday launched a programme to prevent and control hypertension in the country.
Tagged ‘Healthy Heart Africa (HHA)’ the programme is executed by PSI Nigeria and will be implemented in the FCT and 17 states across Nigeria, including Adamawa, Anambra, Akwa-Ibom, Bauchi, Delta, Enugu, Gombe Imo, Jigawa, Kebbi, Kwara, Nasarawa, Ondo, Osun, Oyo, Rivers, and Sokoto States.
- ASUU strike: Kaduna varsity insists on resumption, lecturers adamant
- 2023: Arewa youths unveil campaign office for Tinubu in Abuja
The Minister of Health, Osagie Ehanire, said the programme would contribute to attaining the objective of orienting the health system towards addressing prevention and control of non-communicable diseases at all levels of care and by integrating them into the country’s primary healthcare system.
Ashling Mulvaney, Vice President, Global Sustainability and Access to Healthcare, AstraZeneca, said the programme would strengthen the healthcare system by screening for hypertension, commonly known as high blood pressure, at the primary healthcare level.
Faisal Shuaib, Executive Director, NPCHDA, said: “We encourage people across all 17 implementing states and the Federal Capital Territory to take advantage of the programme by undergoing screening for high blood pressure for early detection and management.”